Small but mighty: Finnish company flags its nanoparticle technology as potential gamechanger for biologics sector
Finland’s Nanoform has announced the launch of its proprietary nanoparticle technology for biologics.
Archives for November 30, 2020
Are stable producer cells the future of viral vector manufacturing and when will allogeneic cell therapy take hold?
From operational uncertainty and outdated manual processes to new cell lines and a potential shift towards allogeneic cell therapy, CRB’s new report - Horizons: Cell and Gene Therapy - finds the biopharma industry at the critical intersection of obstacle...
Could Pfizer's COVID-19 vaccine get the green light in the UK this week?
The UK is set to authorize Pfizer-BioNTech’s COVID-19 vaccine ‘within days’, according to reports.
Moderna submits EUA request for COVID-19 vaccine: "We believe our vaccine will provide a new and powerful tool that may change the course of this pandemic"
Moderna has announced it will submit an Emergency Use Authorization request to the US FDA today for its COVID-19 vaccine candidate. It has also released the Phase 3 primary efficacy analysis, showing 94.1% efficacy.